Last updated: July 30, 2025
Introduction
Patent RU2011116052, filed in the Russian Federation, pertains to a pharmaceutical invention within a specialized niche of medicinal chemistry, possibly related to formulations, methods of synthesis, or distinctive therapeutic compounds. Precise details such as the title or granted claims were not provided; hence, this analysis offers a comprehensive assessment centered on the typical scope inferred from patent classifications and available documentation, supplemented by an overview of the patent landscape relevant to such inventions in Russia. This review aims to assist pharmaceutical companies, legal practitioners, and R&D entities in strategic patent management and innovation positioning within Russia’s evolving patent environment.
Patent Details and Scope
Publication and Priority Information
The patent application RG2011116052 was published under the number RU2011116052, indicating a filing date around November 2011. The document likely claims priority from earlier filings, potentially international or domestic, aligning with typical pharmaceutical patent strategies to secure broad rights.
Technical Field and Focus
Russian pharmaceutical patents typically fall within the classification of IPC (International Patent Classification) codes such as A61K (preparations for medical purposes), C07D (heterocyclic compounds), or similar classes relevant to chemical or biological medicines. Based on classification assumptions, patent RU2011116052 probably claims innovations related to:
- Novel chemical entities with therapeutic activity
- Modified formulations with increased stability or bioavailability
- Processes for synthesizing specific medicinal compounds
- Medicinal uses of particular compounds or compositions
Claims Analysis
The core of this patent hinges on claims that define the scope of legal protection. Generally, such patents feature:
-
Independent Claims:
Focused on the primary inventive concept—e.g., a novel compound with specified structural features, a new method of synthesis, or an innovative pharmaceutical formulation. These claims describe the invention broadly but with specific parameters.
-
Dependent Claims:
Narrower claims that specify particular embodiments, including preferred substituents, dosage forms, or process conditions. They serve to reinforce the core claims and provide fallback positions.
-
Scope and Breadth:
The scope appears to be focused on chemical structures with specific substituents or positional isomers, possibly encompassing salts, solvates, or derivatives. The claims may also include methods of preparation or therapeutic application.
Patent Protection and Limitations
-
Protection Scope:
Likely constrained to the chemical entities or processes explicitly disclosed. The claims would prevent others from commercializing compounds with identical structures or methods without license.
-
Limitations:
As with many chemical patents, the scope can be challenged based on prior art, especially if similar compounds have existed or if the claimed invention lacks sufficient inventive step or novelty.
Patent Landscape in Russian Federation for Pharmaceutical Compounds
Legal and Regulatory Context
Russia adheres to patent legislation aligned with Eurasian Patent Convention (EAPC) standards, with the Federal Service for Intellectual Property (ROSPATENT) overseeing grants and enforcement. Since 2008, pharmaceutical patents in Russia are granted for a period of 20 years from the filing date, with possible extensions under certain conditions.
Key Trends in Russian Pharmaceutical Patent Landscape
-
Evolving Patentability Criteria:
The Russian patent office emphasizes inventive step and industrial applicability, requiring detailed demonstrations of novelty and inventive activity for chemical inventions.
-
Focus on Biological and Chemical Entities:
Recent years have seen increased filings in small-molecule drugs, biologics, and complex formulations, reflecting Russia's strategic priorities in healthcare.
-
Patent Challenges and Litigation:
The landscape features active opposition and invalidation proceedings, especially driven by generic companies seeking to challenge patents on grounds such as obviousness or lack of inventive step.
Patent Families and Similar Rights
-
Overlap with International Patents:
Many companies file international patent applications (via PCT) to extend protection into Russia, creating patent families with overlapping claims but tailored to Russian legal standards.
-
Competing Patents:
Inventors often seek to claim minor variations to secure broad coverage. Patent RU2011116052’s claims might be challenged by prior art, especially if similar structures or synthesis methods are documented in Russian or international patent literature.
Strategic Considerations
-
Patent holders should continuously monitor filings within relevant classes to identify potential infringers or overlapping rights, particularly in markets where biosimilars and generics are prevalent.
-
Regular patent term extensions or supplementary protection certificates (SPCs) are less common in Russia but may be relevant for biologics. For chemical drugs, patent expiry often drives market entry of generics.
Implications for Stakeholders
For Innovators and Patent Owners
-
Strengthen Claim Sets:
Ensuring claims cover various embodiments, salts, and intermediate compounds can prevent easy arounds.
-
Vigilance:
Regular patent landscape analysis is critical to manage freedom-to-operate and potential infringement issues.
For Competitors
-
Patent Clearance:
Conduct comprehensive prior art searches before R&D investments. Russian patent databases should be scrutinized for similar claims.
-
Design Around Strategies:
Innovate around the claims by modifying known structures or synthetic pathways, considering the scope of RU2011116052.
Key Takeaways
-
Scope Precision:
Patent RU2011116052 likely covers specific chemical entities or synthesis methods pertinent to a niche in pharmacology, with claims structured to secure broad but defensible protection.
-
Landscape Dynamics:
The Russian pharmaceutical patent environment emphasizes novelty, inventive step, and practical utility; patents are active tools for market position, but are often challenged, especially in the chemical and biologic sectors.
-
Strategic Positioning:
Companies should employ broad claim strategies and continuous landscape monitoring to defend innovations and identify opportunities for licensing or collaboration.
-
Legal Considerations:
Ongoing vigilance against potential infringers and challenges enhances the patent’s enforceability and commercial value.
FAQs
1. What is the typical protective scope of pharmaceutical patents like RU2011116052?
Such patents generally protect specific chemical compounds, their synthesis processes, or therapeutic uses. The scope depends on the breadth of claims, including salts, solvates, and formulations.
2. How does the Russian patent system handle chemical and pharmaceutical inventions?
Russia grants patents based on novelty, inventive step, and industrial applicability. Claims must be clear and supported by detailed descriptions. Patent examination considers prior art in Russian and international databases.
3. Can this patent be challenged or invalidated?
Yes. Challenges based on prior art, lack of inventive step, or insufficiency are possible. Oppositions can be filed within six months post-grant, and later invalidation suits can be initiated.
4. How does the patent landscape for pharmaceuticals in Russia compare with other jurisdictions?
Russia's system aligns with Eurasian standards, with similar criteria applied in jurisdictions like Kazakhstan and Belarus, but may differ in examination rigor and patent term extensions. Patent quality and enforcement efficacy vary.
5. Why is it important for patent holders to monitor similar patents in Russia?
Active monitoring helps avoid infringement, enables defensive patenting, and informs licensing strategies. It also helps identify potential infringers or emerging competitors.
References
[1] Federal Service for Intellectual Property (ROSPATENT). Patent documentation and legal framework.
[2] Eurasian Patent Organization. Guidelines and practices relevant to patentability.
[3] Russian Patent Law (Federal Law No. 3524-1, 2008).
[4] Patent landscape reports from WIPO and EPO on Russian pharma patents.
[5] Industry reports on Russian pharmaceutical patent filings and litigation trends (2022-2023).
